Growth Metrics

Galectin Therapeutics (GALT) Net Income Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 32.79%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 60.43%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -46.86%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.80%
7 Evaxion A 64.16 Bn 64.14 Bn - 19.97%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 47.10%
10 Galectin Therapeutics 165.77 Mn 151.67 Mn - 17.55%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 17.55%
Dec 31, 2025 21.50%
Sep 30, 2025 10.62%
Jun 30, 2025 13.39%
Mar 31, 2025 1.85%
Dec 31, 2024 -22.27%
Sep 30, 2024 -8.26%
Jun 30, 2024 -14.67%
Mar 31, 2024 -18.77%
Dec 31, 2023 -9.59%
Sep 30, 2023 -18.70%
Jun 30, 2023 -16.24%
Mar 31, 2023 -44.63%
Dec 31, 2022 -28.54%
Sep 30, 2022 -44.35%
Jun 30, 2022 -48.85%
Mar 31, 2022 -62.34%
Dec 31, 2021 -36.15%
Sep 30, 2021 -44.19%
Jun 30, 2021 -29.18%
Mar 31, 2021 -14.18%
Dec 31, 2020 -49.08%
Sep 30, 2020 -10.47%
Jun 30, 2020 -10.69%
Mar 31, 2020 10.36%
Dec 31, 2019 -3.82%
Sep 30, 2019 14.95%
Jun 30, 2019 18.41%
Mar 31, 2019 29.58%
Dec 31, 2018 13.24%
Sep 30, 2018 22.39%
Jun 30, 2018 6.13%
Mar 31, 2018 4.09%
Dec 31, 2017 13.96%
Sep 30, 2017 -8.35%
Jun 30, 2017 -10.27%
Mar 31, 2017 -0.66%
Dec 31, 2016 -17.93%
Sep 30, 2016 -8.51%
Jun 30, 2016 -29.45%
Mar 31, 2016 -28.52%
Dec 31, 2015 -25.27%
Sep 30, 2015 -26.78%
Jun 30, 2015 -20.40%
Mar 31, 2015 -35.26%
Dec 31, 2014 -3.38%
Sep 30, 2014 -19.55%
Jun 30, 2014 -4.02%
Mar 31, 2014 -34.08%
Dec 31, 2013 -29.56%
Sep 30, 2013 -43.09%
Jun 30, 2013 -23.55%